Association between Body Mass Index and Response to Duloxetine for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in SWOG S1202

BACKGROUND: Aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS) negatively impact adherence and persistence with therapy. In SWOG S1202, patients with AIMSS treated with duloxetine, a serotonin norepinephrine reuptake inhibitor, reported improvement in pain by 12 weeks compared to p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer
Autors principals: Henry, N. Lynn, Unger, Joseph M., Till, Cathee, Schott, Anne F., Crew, Katherine D., Lew, Danika L., Fisch, Michael J., Moinpour, Carol M., Wade, James L., Hershman, Dawn L.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6675412/
https://ncbi.nlm.nih.gov/pubmed/30861098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32024
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars